The correctional modification of inflammatory response at the experimental acute pancreatitis

Alex P. Sarapultsev, Oleg N. Chupakhin, Maxim А. Rantsev, Petr А. Sarapultsev, Irina G. Danilova, Svetlana U. Medvedeva, Larisa P. Sidorova

Federal State Autonomous Educational Institution of Higher Professional Education, Ural Federal University named after the first President of Russia B. N. Yeltsin, Ekaterinburg, Russia.
Institute of Immunology and Physiology of the Ural Branch of the RAS, Ekaterinburg, Russia.
The IJ Postovsky Institute of Organic Synthesis, the Ural Branch of the RAS, Ekaterinburg, Russia.

DOI: 10.4236/abb.2012.324062                

Abstract

This study investigated the effects of the L-17 compound of the group of substituted 5R1, 6H2-1,3,4- thiadiazine-2-amines on the possibility of inflammatory reaction evolvement correction in experimental acute pancreatitis. The study was based upon recent clinical and experimental work which demonstrated the role of local and systemic inflammatory reactions in pancreatonecrosis. Pancreatonecrosis modeling in rats was performed in accordance with the author’s modification of ligation model of acute pancreatitis. The biochemical and hematological analysis were performed in all groups at day 1. For microscopic analysis, five histological slices of each animal were analyzed. The main group, consisting of 15 animals with the average body weight 223 g each, got intraperitoneal injection of L-17 compound, dozed 40 mg/kg in an hour after surgery of pancreatitis formation. Later on, a 40 mg/kg doze of L-17 compound was repeatedly injected as often as once every 24 hours. Already during the 1st day of the experiment, no leucopenia was observed and the signs of proliferative inflammation were detected. Later, at the background of L-17 compound introduction (5th day of the experiment) the necrosis area got surrounded by demarcation bank, and further on (by the 7th day) had been entirely replaced by granulation tissue. Thus, the application of L-17 compound in experimental acute pan-creatitis results in replacement of destructive purulent inflammation by exudative-proliferative one, prevents lympho- and monocytopenia development, minimizes amylase and pancreatic ferments level during the first day of development of the disease and cuts down the lethality rate as result of pancreatonecrosis complications twofold.

Keywords

L-17 Compound; Experimental Model; Inflammation; Acute Pancreatitis

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	Atanov, Y.P. (1997) Purulent pancreatitis. Khirurgia, 8, 20-24.
[2]	Banks, P.A. (1979) Pancreatitis. Plenum, New York.
[3]	Gotzinger, P., Sautner, T., Kriwanek S., Beckerhinn P, Barlan, M., Armbruster, C., Wamser, P., Fugger, R. (2002) Surgical treatment for severe acute pancreatitis: extent and surgical control of necrosis determine outcome. World J Surg, 26(4), 474–478.
[4]	Banks, P.A., Freeman, M.L. (2006) Practice guidelines in acute pancreatitis. Am J Gastroenterol, 101, 2379–2400.
[5]	Whitcomb, D.C. (2006) Acute pancreatitis. N Engl J Med, 354, 2142–2150.
[6]	Beger, H.G., Bittner, R., Block, S., Buchler, M.W. (1986) Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology, 91, 433-438.
[7]	Garelik, P.V., Tsilindz, I.T., Pakulnevich, Y.F., Mileshko, M.I. (2006) Use of low-invasive techniques in acute pancreatitis treatment. Proceedings of 10th Jubilee Moscow International Congress on Endoscopic Surgery, Moscow, 19-21 April 2006, 56-57.
[8]	Sotnichenko, B.A., Markelova, E.V., Salienko, S.V. (2005) Treatment of acute destructive pancreatitis with recombinant interleukin-2. Khirurgia, 5, 20-22.
[9]	Bradley, E.L. III. (1993) A clinically based classification system for acute pancreatitis: summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga., Arch Surg, 128, 586-590.
[10]	Nesterenko, Y.A., Laptev, V.V., Michailousov, S.V. (2004) Diagnostics and treatment of acute pancreatitis. Binom, Moscow.
[11]	Sarapultsev, P.A., Chupakhin, O.N., Sarapultsev, A.P., Rantsev, M.A., Sidorova, L.P., Medvedeva, S.U., Danilova, I.G. (2012) New insights in to the treatment of myocardial infarction. International Journal Experiment Pathol, 93(1), 18-23.
[12]	Novikova, A.P., Perova, N.M., Chupakhin, O.N. (1992) Synthesis and properties of functional derivatives of 1,3,4-thiadiazines and condensed systems based on these compounds. Chem Heterocyclic Comp, 11, 1443–1457.
[13]	Logvinova, Y.S., Vasil’eva, T.M., Makarov, V.A., Chupakhin, O.N., Sidorova, L.P., Rusinov, V.L. (2010) The effect of new compounds 1,3,4-thiadiazine class on platelet aggregation in vitro and ex vivo. Exp Clin Pharmacol, 8, 21–26.
[14]	(1996) Guide for the Care and Use of Laboratory Animals.The National Academies Press, Washington DC.
[15]	Flecknell, P.A. (1987) Laboratory animal anesthesia. Academic Press, London.
[16]	Swindle, M.M., Adams, R.J. eds. (1988) Experimental surgery and physiology: induced animal models of human disease. Williams and Wilkins, Baltimore MD.
[17]	Bancroft, J.D., Stevens, A. (1996) Theory and Practice of Histological Techniques. 4th Edition, Churchill Livingstone, New York.
[18]	Lillie, R.D. (1977) HJ Conn's Biological Stains. 4th Edition, Williams and Wilkins, Baltimore.
[19]	Giknis, M.L.A., Clifford, C.B. Clinical laboratory parameters for Crl:WI (Han). (2008) Charles River Laboratories. http://info.criver.com/flex_content_area/documents/rm_rm_r_Wistar_Han_clin_lab_parameters_08.pdf. Consulted 26-8-2009.
[20]	Goltsev, K.A., Babinets, O.M., Kozhina, O.Y., Ostankova, L.V., Goltsev, A.N. (2011) Effect of Cryopreserved Human Cord Blood Problems of cryobiology, 21(2), 179-191.
[21]	De Beaux, A.C., Goldie, A.S., Ross, J.A., Carter, D.C., Fearon, K.C. (1996) Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg, 83(3), 349-53.
[22]	Ohshio, G., Saluja, A., Steer, M.L. (1991) Effects of short-term pancreatic duct obstruction in rats. Gastroenterology, 104, 1768 –1779.
[23]	Büchler, M.W., Gloor, B., Müller, C.A., Friess, H., Seiler, C.A., Uhl, W. (2000) Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg, 232, 619–626.
[24]	Jimenez, H., Aldrete, J.S. (1983) Clinical implications derived from the morphological classification of 89 patients with acute pancreatitis. J Clin Gastroenterol, 5, 137–142.
[25]	Leger, L., Chiche, B., Louvel, A. (1981) Pancreatic necrosis and acute pancreatitis. World J Surg, 5(3), 315–317.
[26]	Tolstoy, A.D., Panov, V.P., Krasnorogov, V.B., Vashetko, P.V., Skorodumov, A.V. (2003) Parapancreatitis. Yasniy Svet, St. Petersburg